Follow us for updates
© 2022 reportr.world
Read the Story →

Duterte Defends Presidential Guards for Taking COVID Vaccine

Don't call PSG to congressional hearings, he said.
Jan 4, 2021
Photo/s: Toto Lozano/Presidential Photo
Shares

President Rodrigo Duterte said his guards from the PSG got COVID-19 vaccines to protect themselves from the virus, defending them from critics who pointed out that Filipino authorities had not approved the China-made jab.

Duterte said he was "not keen" on allowing the Presidential Security Group to testify before investigation on the vaccination, which was not sanctioned by the Food and Drug Administration. The Senate has set its inquiry on the matter on Jan. 11.

For members of the PSG who protect the President round the clock, it's "a matter of self-preservation," Duterte said.

"They have the right to live and invoke self-preservation, the right to self defense," he said. "The enemy is COVID."

ALSO READ:

Soldiers Guarding Duterte First to Get COVID Vaccine in Philippines

What Duterte Said in His Weekly Speech (Jan. 4) 

The soldiers got the Sinopharm vaccines from China even as the FDA had not approved any of the several vaccine candidates for commercial use.

Continue reading below ↓

"You can say all the rules in this world, there will always be an exception," he said.

ALSO READ:

COVID Vaccine Prices, Efficacy, Safety Compared

COVID Vaccines Need FDA Approval, Here's Why It's Important

Continue reading below ↓
Recommended Videos
Latest Headlines
Read Next
Recent News
Appointment announced a day before Marcos' inauguration.
More time for K-drama, books, and mornings without alarms.
With the reopening of several local destinations, this app has never been more timely.
You can participate in person and virtually.
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to reportr.world newsletter, you agree to our Terms of Service and Privacy Policy.